iRhythm Technologies, Inc. (FRA:I25)

Market Cap	5.22B
Revenue (ttm)	598.80M
Net Income (ttm)	-43.86M
Shares Out	n/a
EPS (ttm)	-1.38
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	159.00
Previous Close	158.00
Day's Range	155.00 - 159.00
52-Week Range	75.50 - 179.00
Beta	n/a
RSI	57.70
Earnings Date	Feb 20, 2026

About iRhythm Technologies

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. It also provides Zio Monitor System, a prescription-only remote electrocardiogram (ECG) monitoring system consisting a patch ECG monitor t...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2006
• Employees: 2,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: I25

Financial Performance

In 2024, iRhythm Technologies's revenue was $591.84 million, an increase of 20.13% compared to the previous year's $492.68 million. Losses were -$113.29 million, -8.20% less than in 2023.

Financial numbers in USD